Information Provided By:
Fly News Breaks for June 26, 2015
EXAS
Jun 26, 2015 | 07:17 EDT
Canaccord said Exact Sciences made a compelling case as a sustainable platform growth company at its analyst day. The firm cited its raised guidance, rising compliance rate and pancreatic pipeline. Canaccord reiterated its Buy rating and $32 price target on Exact Science shares.
News For EXAS From the Last 2 Days
There are no results for your query EXAS